Moderating role of age in the relationship between ingroup range and intention to help during the COVID-19 pandemic.

Publication date: Jan 24, 2025

This study explored the relationship between the ingroup range of individuals and their willingness to assist various social groups during the COVID-19 pandemic and whether or not age moderates this relationship. A total of 291 South Koreans (Mage = 31. 91 years, SD = 11. 99) participated in an online survey and provided data on ingroup range, intention to provide help, and age. The results demonstrated that individuals with a broader ingroup range displayed a stronger willingness to distribute quarantine supplies for COVID-19 across diverse social groups (β = .12, p < .05). This finding aligned with the ingroup bias phenomenon, in which individuals tend to favor one's group. Importantly, age moderated the association between ingroup range and willingness to help (B = -. 19, p < .05). Specifically, the intention of younger individuals (θX → Y|(M = -11. 985) = 4. 40, CI = 1. 79-7. 01) and middle-aged individuals (θX → Y|(M = .000) = 2. 14, CI = .31-3. 98) to assist diverse social groups significantly varied according to their ingroup range, whereas no such relationship existed among older individuals (θX → Y|(M = 11. 985) = -. 11, CI = -2. 64-2. 42). We provided an in-depth discussion into the potential reasons that underlie the stronger willingness of older individuals to extend aid beyond their ingroup range during the pandemic compared with those of younger individuals. We then suggested strategies for encouraging acts of prosociality during crises, such as the COVID-19 pandemic, which particularly emphasize the pattern observed in younger participants with a narrow ingroup range.

Open Access PDF

Concepts Keywords
Koreans Adolescent
Mage Adult
Pandemic Age Factors
Relationship Aged
COVID-19
Female
Humans
Intention
Male
Middle Aged
Pandemics
Quarantine
Republic of Korea
SARS-CoV-2
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease IDO role
disease MESH COVID-19 pandemic
drug DRUGBANK L-Tyrosine
drug DRUGBANK Methionine
drug DRUGBANK Fenamole
disease MESH emergency
pathway REACTOME Reproduction
disease MESH lifestyle
disease MESH panic
disease MESH infection
disease MESH infectious diseases
drug DRUGBANK Coenzyme M
disease IDO intervention
disease MESH death
disease IDO history
drug DRUGBANK Methylergometrine
disease IDO process
disease MESH tic
drug DRUGBANK Creatinolfosfate
disease MESH marital status
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH educational attainment
drug DRUGBANK Proline
drug DRUGBANK Nonoxynol-9
disease MESH uncertainty
drug DRUGBANK Dimethyltryptamine

Original Article

(Visited 1 times, 1 visits today)